(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.
The three biggest winners today are AVENIR TELECOM, HOTELS DE PARIS, and ACTEOS.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| AVENIR TELECOM (AVT.PA) | 0.33 | 28.16% | 2023-03-01 11:38:50 |
| HOTELS DE PARIS (HDP.PA) | 1.57 | 17.16% | 2023-03-01 11:51:45 |
| ACTEOS (EOS.PA) | 1.92 | 14.63% | 2023-03-01 11:36:52 |
| IDEX BIOMETRICS (IDEX.OL) | 0.97 | 12.14% | 2023-03-01 11:30:40 |
| FIN.OUEST AFRICAIN (FOAF.PA) | 42.00 | 9.37% | 2023-03-01 11:49:45 |
| MEDISTIM (MEDI.OL) | 239.00 | 9.13% | 2023-03-01 11:31:16 |
| ATOS (ATO.PA) | 14.60 | 8.67% | 2023-03-01 11:38:36 |
| SMCP (SMCP.PA) | 8.03 | 8.65% | 2023-03-01 11:03:34 |
| SCANA (SCANA.OL) | 1.59 | 7% | 2023-03-01 11:33:44 |
| OSE IMMUNO (OSE.PA) | 5.96 | 6.43% | 2023-03-01 11:01:11 |
The three biggest losers today are NEOEN, ALLFUNDS GROUP, and HÖEGH AUTOLINERS.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| NEOEN (NEOEN.PA) | 29.44 | -13.82% | 2023-03-01 11:00:40 |
| ALLFUNDS GROUP (ALLFG.AS) | 7.16 | -13.48% | 2023-03-01 11:00:23 |
| HÖEGH AUTOLINERS (HAUTO.OL) | 59.90 | -12.04% | 2023-03-01 11:30:36 |
| EUROFINS SCIENT. (ERF.PA) | 58.10 | -11.97% | 2023-03-01 11:48:53 |
| MOTA ENGIL (EGL.LS) | 1.69 | -9.25% | 2023-03-01 11:20:45 |
| PROACTIS SA (PROAC.PA) | 0.11 | -8.7% | 2023-03-01 08:02:35 |
| DIEGEM KENNEDYCERT (DIEG.BR) | 105.14 | -7.74% | 2023-03-01 11:08:15 |
| TELEVERBIER (TVRB.PA) | 40.20 | -6.51% | 2023-03-01 11:04:46 |
| INTEROIL EXPL PROD (IOX.OL) | 1.03 | -5.5% | 2023-03-01 11:30:42 |
| ASM INTERNATIONAL (ASM.AS) | 307.10 | -4.92% | 2023-03-01 11:00:37 |
Winners today
1. AVENIR TELECOM (AVT.PA)
28.16% Price Change
Avenir Telecom S.A. retails and distributes mobiles, smartphones, and accessories. The company offers chargers, cables, protection screens and cases, memory, and USB products, multiports, HUBS, and other products under the Energizer brand. It also designs and manufactures accessories under Oxo brand. The company sells its products in 55 countries. Avenir Telecom S.A. was founded in 1989 and is based in Marseille, France.
CAC 40 ended the session with AVENIR TELECOM rising 28.16% to €0.33 on Wednesday, following the last session’s downward trend. CAC 40 fell 0.46% to €7,234.25, after three consecutive sessions in a row of losses, on what was a somewhat negative trend trading session today.
Earnings Per Share
As for profitability, AVENIR TELECOM has a trailing twelve months EPS of €-0.023.
Volatility
AVENIR TELECOM’s last week, last month’s, and last quarter’s current intraday variation average was 17.52%, 6.61%, and 8.85%.
AVENIR TELECOM’s highest amplitude of average volatility was 21.68% (last week), 11.64% (last month), and 8.85% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AVENIR TELECOM’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for AVENIR TELECOM is 10112600 which is 95.71% above its average volume of 5167130.
More news about AVENIR TELECOM.
2. HOTELS DE PARIS (HDP.PA)
17.16% Price Change
Les Hôtels de Paris SA operates and manages hotels in Paris. As of December 31, 2021, it operated 17 hotels in Paris, 1 hotel in St Tropez, and 1 hotel in Marrakech. The company was incorporated in 1992 and is headquartered in Paris, France.
CAC 40 ended the session with HOTELS DE PARIS rising 17.16% to €1.57 on Wednesday while CAC 40 fell 0.46% to €7,234.25.
Earnings Per Share
As for profitability, HOTELS DE PARIS has a trailing twelve months EPS of €-2.341.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, HOTELS DE PARIS’s stock is considered to be overbought (>=80).
More news about HOTELS DE PARIS.
3. ACTEOS (EOS.PA)
14.63% Price Change
ACTEOS S.A. designs, develops, integrates, and provides software and related services in the field of supply chain management in France, Germany, Lebanon, and internationally. It offers Acteos suite, which include forecasting and procurement system for point of sales/e-business/distribution centers; transportation management system to organize and manage transport activities; and warehouse management system, a modular solution to manage customers' warehouses. The company also provides software as a service, hotline, technical project management, and consulting services. ACTEOS S.A. was founded in 1986 and is headquartered in Roubaix, France.
CAC 40 ended the session with ACTEOS rising 14.63% to €1.92 on Wednesday while CAC 40 slid 0.46% to €7,234.25.
Earnings Per Share
As for profitability, ACTEOS has a trailing twelve months EPS of €0.04.
PE Ratio
ACTEOS has a trailing twelve months price to earnings ratio of 48. Meaning, the purchaser of the share is investing €48 for every euro of annual earnings.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ACTEOS’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for ACTEOS is 5587 which is 173.33% above its average volume of 2044.
Moving Average
ACTEOS’s value is way above its 50-day moving average of €1.60 and way above its 200-day moving average of €1.65.
More news about ACTEOS.
4. IDEX BIOMETRICS (IDEX.OL)
12.14% Price Change
IDEX Biometrics ASA engages in the design, development, and sale of fingerprint authentication solutions in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific regions. The company's fingerprint authentication solutions are used primarily in contactless financial payment, access control, and smart cards, as well as card-based devices for the storage of digital currencies. It primarily serves manufacturers of smart cards for financial payment applications and biometric payment card markets. IDEX Biometrics ASA was incorporated in 1996 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with IDEX BIOMETRICS jumping 12.14% to €0.97 on Wednesday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI jumped 0.13% to €1,242.54, after two consecutive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, IDEX BIOMETRICS has a trailing twelve months EPS of kr-0.51.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -107.86%.
Moving Average
IDEX BIOMETRICS’s value is way above its 50-day moving average of kr0.88 and below its 200-day moving average of kr0.99.
Volume
Today’s last reported volume for IDEX BIOMETRICS is 4450090 which is 8.75% below its average volume of 4876880.
More news about IDEX BIOMETRICS.
5. FIN.OUEST AFRICAIN (FOAF.PA)
9.37% Price Change
Fin.Ouest Africain provides various financial services. It offers car, personal, business risk, transportation, and other property and casualty insurance products; and life insurance products for individuals, private and public companies, and organizations. It also invests in bonds and shares in listed and unlisted companies; and provides wealth management services, including building and managing real estate assets. The company was founded in 1951 and is based in Dakar, Senegal.
CAC 40 ended the session with FIN.OUEST AFRICAIN rising 9.37% to €42.00 on Wednesday while CAC 40 fell 0.46% to €7,234.25.
Volatility
FIN.OUEST AFRICAIN’s last week, last month’s, and last quarter’s current intraday variation average was 20.36%, 15.86%, and 17.54%.
FIN.OUEST AFRICAIN’s highest amplitude of average volatility was 20.36% (last week), 17.64% (last month), and 17.54% (last quarter).
More news about FIN.OUEST AFRICAIN.
6. MEDISTIM (MEDI.OL)
9.13% Price Change
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with MEDISTIM rising 9.13% to €239.00 on Wednesday, after three sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.13% to €1,242.54, after two consecutive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, MEDISTIM has a trailing twelve months EPS of kr5.31.
PE Ratio
MEDISTIM has a trailing twelve months price to earnings ratio of 45.01. Meaning, the purchaser of the share is investing kr45.01 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.12%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
MEDISTIM’s EBITDA is 82.93.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, MEDISTIM’s stock is considered to be overbought (>=80).
Revenue Growth
Year-on-year quarterly revenue growth grew by 14.1%, now sitting on 458.69M for the twelve trailing months.
Yearly Top and Bottom Value
MEDISTIM’s stock is valued at kr239.00 at 21:40 EST, way below its 52-week high of kr330.00 and way above its 52-week low of kr184.80.
More news about MEDISTIM.
7. ATOS (ATO.PA)
8.67% Price Change
Atos SE provides digital transformation solutions and services worldwide. It offers cloud, cybersecurity, and computing solutions, as well as end-to-end vertical solutions, data platforms, and infrastructure solutions. The company's solutions include advanced computing; analytics, artificial intelligence, and automation; cloud solutions; customer journey analytics and digital customer experience; advance detection and response, data protection and governance, and trusted digital identities, as well as digital workplace, hybrid cloud, and IoT and OT security; digital consulting; digital workplace; and edge computing and Internet of things. It also offers infrastructure and foundation services. It serves energy and utilities, financial services and insurance, healthcare and life sciences, manufacturing, public sector and defense, telecommunications and media, transport and logistics, and retail industries. Atos SE was incorporated in 1982 and is headquartered in Bezons, France.
CAC 40 ended the session with ATOS jumping 8.67% to €14.60 on Wednesday, after two successive sessions in a row of gains. CAC 40 slid 0.46% to €7,234.25, after three consecutive sessions in a row of losses, on what was a somewhat down trend exchanging session today.
Earnings Per Share
As for profitability, ATOS has a trailing twelve months EPS of €5.05.
PE Ratio
ATOS has a trailing twelve months price to earnings ratio of 2.89. Meaning, the purchaser of the share is investing €2.89 for every euro of annual earnings.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ATOS’s stock is considered to be oversold (<=20).
More news about ATOS.
8. SMCP (SMCP.PA)
8.65% Price Change
SMCP S.A. operates as a ready-to-wear and accessories retail company in France and internationally. It designs, markets, and sells women's wear, men's wear, and accessories. The company sells its products through a network of points of sale and websites under four brands, including Sandro, Maje, Claudie Pierlot, and De Fursac. The company was founded in 1984 and is headquartered in Paris, France. SMCP S.A. is a former subsidiary of Shandong Ruyi Technology Group Co., Ltd.
CAC 40 ended the session with SMCP rising 8.65% to €8.03 on Wednesday while CAC 40 slid 0.46% to €7,234.25.
Earnings Per Share
As for profitability, SMCP has a trailing twelve months EPS of €-1.38.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.88%.
Volume
Today’s last reported volume for SMCP is 215745 which is 180.33% above its average volume of 76961.
Yearly Top and Bottom Value
SMCP’s stock is valued at €8.03 at 21:40 EST, higher than its 52-week high of €7.59.
More news about SMCP.
9. SCANA (SCANA.OL)
7% Price Change
Scana ASA provides equipment and services to the maritime industry. The company offers valve remote control systems and mooring solutions to vessels, rigs, and floating structures serving the shipping, oil and gas, aquaculture, and energy industries. It also engages in the design and integration of electrical power systems, electrical infrastructure, and energy storage systems and control systems; and provides standard and customized containers/module solutions, as well as various types of welded constructions for offshore and onshore projects. In addition, the company is involved in the planning and execution of insulation, scaffolding, and surface treatment services; and rig, capping, equipment support, make and break, IMR lifecycle, welding, and asset integrity management services to drilling industry, as well as offers riser applications to the oil and gas industry. The company was formerly known as Incus Investor ASA and changed its name to Scana ASA in May 2020. Scana ASA was founded in 1646 and is headquartered in Bergen, Norway.
Oslo Børs Benchmark Index_GI ended the session with SCANA jumping 7% to €1.59 on Wednesday while Oslo Børs Benchmark Index_GI jumped 0.13% to €1,242.54.
Earnings Per Share
As for profitability, SCANA has a trailing twelve months EPS of kr0.43.
PE Ratio
SCANA has a trailing twelve months price to earnings ratio of 3.7. Meaning, the purchaser of the share is investing kr3.7 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -14.97%.
Volume
Today’s last reported volume for SCANA is 4283540 which is 97.62% above its average volume of 2167460.
Earnings Before Interest, Taxes, Depreciation, and Amortization
SCANA’s EBITDA is 55.39.
Volatility
SCANA’s last week, last month’s, and last quarter’s current intraday variation average was 0.81%, 0.54%, and 2.95%.
SCANA’s highest amplitude of average volatility was 3.54% (last week), 2.23% (last month), and 2.95% (last quarter).
Revenue Growth
Year-on-year quarterly revenue growth grew by 344.1%, now sitting on 911.7M for the twelve trailing months.
More news about SCANA.
10. OSE IMMUNO (OSE.PA)
6.43% Price Change
OSE Immunotherapeutics SA, a clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally. Its products include Tedopi that is in Phase III clinical trial for the treatment of non-small cell lung cancer, as well as in Phase II clinical trial to pancreatic and ovarian cancer; OSE-279, which is in a Phase I/II clinical trial in patients with advanced solid tumors or lymphomas; OSE-127, a humanized monoclonal antibody that is in Phase II clinical trial for the treatment of ulcerative colitis, as well as Sjögren's Syndrome; and FR104, which is in Phase I clinical trial for the treatment of rheumatoid arthritis. The company is also developing BI 765063, which is in Phase I clinical trial to treat solid tumors; OSE-230, an agonist antibody against ChemR23 to resolve chronic inflammation; CLEC-1, a therapeutic target in immune-oncology and identified monoclonal antibody antagonists; and BiCKI, a novel bispecific checkpoint inhibitor platform that targets PD-1 to fight primary and secondary resistance mechanisms developed by cancers. OSE Immunotherapeutics SA has collaborations and partnerships with GERCOR, ARCAGY-GINECO, Foundation FoRT, and Nantes University Hospital; and Boehringer Ingelheim, MabSilico, CKD, Servier, Veloxis Pharmaceuticals, and Chong Kun Dang Pharmaceutical Corporation. The company was formerly known as OSE Pharma SA and changed its name to OSE Immunotherapeutics SA in May 2016. OSE Immunotherapeutics SA was founded in 2012 and is headquartered in Nantes, France.
CAC 40 ended the session with OSE IMMUNO rising 6.43% to €5.96 on Wednesday while CAC 40 fell 0.46% to €7,234.25.
Earnings Per Share
As for profitability, OSE IMMUNO has a trailing twelve months EPS of €-0.41.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -14.81%.
More news about OSE IMMUNO.
Losers Today
1. NEOEN (NEOEN.PA)
-13.82% Price Change
Neoen S.A., an independent renewable energy production company, engages in the design, development, finance, construction project management, and operation of renewable energy power plants. The company operates solar, wind, and energy storage plants. It operates in Argentina, Australia, Croatia, Ecuador, United States, Finland, France, Ireland, Italy, Jamaica, Mexico, Mozambique, Portugal, El Salvador, Sweden, and Zambia. Neoen S.A. was incorporated in 2008 and is headquartered in Paris, France. Neoen S.A. is a subsidiary of Impala SAS.
CAC 40 ended the session with NEOEN sliding 13.82% to €29.44 on Wednesday, following the last session’s upward trend. CAC 40 fell 0.46% to €7,234.25, after three sequential sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.
Earnings Per Share
As for profitability, NEOEN has a trailing twelve months EPS of €0.11.
PE Ratio
NEOEN has a trailing twelve months price to earnings ratio of 267.64. Meaning, the purchaser of the share is investing €267.64 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.05%.
Yearly Top and Bottom Value
NEOEN’s stock is valued at €29.44 at 21:40 EST, under its 52-week low of €30.28.
More news about NEOEN.
2. ALLFUNDS GROUP (ALLFG.AS)
-13.48% Price Change
Allfunds Group plc provides B2B WealthTech platforms connecting fund houses and distributors in the United Kingdom and internationally. It operates an open-architecture platform that provides a marketplace and digital solutions matching fragmented demand for asset management products from distributors with fragmented supply of products from fund houses. Its ecosystem covers fund distribution value chain and investment cycle, including via Allfunds Connect, a suite of SaaS-enabled digital, data, and analytics tools. The company also provides asset holding, banking and investment, representation, computer programming and technology development, and institutional intermediation services, as well as research and regulatory services. Allfunds Group plc was founded in 2000 and is based in London, the United Kingdom.
AEX-Index ended the session with ALLFUNDS GROUP dropping 13.48% to €7.16 on Wednesday, following the last session’s downward trend. AEX-Index slid 0.47% to €749.38, following the last session’s downward trend on what was a somewhat bearish trend exchanging session today.
Earnings Per Share
As for profitability, ALLFUNDS GROUP has a trailing twelve months EPS of €0.16.
PE Ratio
ALLFUNDS GROUP has a trailing twelve months price to earnings ratio of 44.72. Meaning, the purchaser of the share is investing €44.72 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.09%.
More news about ALLFUNDS GROUP.
3. HÖEGH AUTOLINERS (HAUTO.OL)
-12.04% Price Change
Höegh Autoliners ASA engages in the deep sea transportation of roll-on roll-off (RoRo) cargoes worldwide. The company offers transportation services for agricultural machinery, automotive, boats and yachts, breakbulk cargoes and carries, construction and mining equipment, machineries, power generation and distribution equipment, railcars and tramways, trucks, buses, and trailers. It also provides shortsea, terminal, and supply chain management services. The company was founded in 1927 and is based in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with HÖEGH AUTOLINERS sliding 12.04% to €59.90 on Wednesday, after four sequential sessions in a row of gains. Oslo Børs Benchmark Index_GI rose 0.13% to €1,242.54, after two successive sessions in a row of gains, on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, HÖEGH AUTOLINERS has a trailing twelve months EPS of kr17.46.
PE Ratio
HÖEGH AUTOLINERS has a trailing twelve months price to earnings ratio of 3.43. Meaning, the purchaser of the share is investing kr3.43 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.04%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, HÖEGH AUTOLINERS’s stock is considered to be oversold (<=20).
Sales Growth
HÖEGH AUTOLINERS’s sales growth for the current quarter is 232.7%.
More news about HÖEGH AUTOLINERS.
4. EUROFINS SCIENT. (ERF.PA)
-11.97% Price Change
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of approximately 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agro-science, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, and healthcare and cosmetics; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include product compliance and audit, testing, certifications and approvals, inspections, training courses, and digital media and cyber security for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, labelling, law, heavy metals, identity preservation, mealtime, molecular and microbiology, mycotoxins, nutritional analyses, organic containments, packaging/migration, radioactivity, rapidest, sensorsy and consumer research, trainings, veterinary drug residues, and vitamins services. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and technologies services. It operates approximately 900 laboratories in 54 countries. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.
CAC 40 ended the session with EUROFINS SCIENT. falling 11.97% to €58.10 on Wednesday while CAC 40 dropped 0.46% to €7,234.25.
Earnings Per Share
As for profitability, EUROFINS SCIENT. has a trailing twelve months EPS of €4.12.
PE Ratio
EUROFINS SCIENT. has a trailing twelve months price to earnings ratio of 14.11. Meaning, the purchaser of the share is investing €14.11 for every euro of annual earnings.
Volume
Today’s last reported volume for EUROFINS SCIENT. is 1051060 which is 144.42% above its average volume of 430021.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUROFINS SCIENT.’s stock is considered to be overbought (>=80).
Volatility
EUROFINS SCIENT.’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.99%, a positive 0.07%, and a positive 1.59%.
EUROFINS SCIENT.’s highest amplitude of average volatility was 1.80% (last week), 1.53% (last month), and 1.59% (last quarter).
More news about EUROFINS SCIENT..
5. MOTA ENGIL (EGL.LS)
-9.25% Price Change
Mota-Engil, SGPS, S.A. provides construction services for public and private customers in Europe, Africa, and Latin America. It constructs infrastructure projects, including airports, railways, hydraulic, ports, roads, and urban facilities; and agricultural and industrial, public building, office and commerce, housing, and silo and chimney projects, as well as provides buildings rehabilitation services. The company also collects, treats, recovers, and disposes urban solid, non-hazardous, and industrial waste; explores mineral resources; extracts gravel, sand, and crushed stone; generates and distributes electric energy; and produces hydroelectric energy. In addition, it designs and constructs social housing; markets, manages, and exploits technological and industrial business parks; develops real estate; manages financial holdings; and constructs, manages, and maintains golf courses. Further, the company provides urban cleaning, terminal exploration, inspection, business administration, restoration, commercial, sea transport, sustainable mobility, shipping, and civil engineering and architecture services; and involved in the tourism, tourist entertainment, road signs, hotel, restaurant, oil recycling, and landscape gardening activities. Additionally, it designs, constructs, manages, and exploits parking lots; rents construction equipment; manufactures and trades clay materials; manufactures prestressed and iron-derived products; trades fuels and related products; and explores landfills. The company engages in the railway transportation of goods, stainless steel works, maintenance and operation of facilities, insurance mediation, and finance and consulting activities. It also designs, installs, develops, and maintains ITS; and operates industrial slaughterhouse. The company was founded in 1946 and is headquartered in Porto, Portugal. Mota-Engil, SGPS, S.A. operates as a former subsidiary of Mota Gestao E Participacoes SGPS, SA.
PSI ended the session with MOTA ENGIL falling 9.25% to €1.69 on Wednesday while PSI fell 1.44% to €5,969.73.
Earnings Per Share
As for profitability, MOTA ENGIL has a trailing twelve months EPS of €-0.09.
More news about MOTA ENGIL.
6. PROACTIS SA (PROAC.PA)
-8.7% Price Change
Proactis SA provides source-to-pay software solution. It operates software platform that will give control over business spend. It also offers procurement solutions that provide purchasing professionals with the tools they need for purchasing process for routine goods and services, capital goods, and major projects. In addition, it offers invoice capture services, system administration, supplier onboarding, and tail spent management services. Further, Its solutions integrate with various ERP or financial systems. The company was formerly known as HUBWOO and changed its name to Proactis SA in January 2019. The company is based in Suresnes, France. Proactis SA operates as a subsidiary of Proactis Euro Hedgeco Limited.
CAC 40 ended the session with PROACTIS SA falling 8.7% to €0.11 on Wednesday while CAC 40 slid 0.46% to €7,234.25.
Earnings Per Share
As for profitability, PROACTIS SA has a trailing twelve months EPS of €-0.072.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.69%.
Moving Average
PROACTIS SA’s worth is higher than its 50-day moving average of €0.11 and below its 200-day moving average of €0.12.
Yearly Top and Bottom Value
PROACTIS SA’s stock is valued at €0.11 at 21:40 EST, way below its 52-week high of €0.15 and way above its 52-week low of €0.08.
More news about PROACTIS SA.
7. DIEGEM KENNEDYCERT (DIEG.BR)
-7.74% Price Change
Immolease Trust NV operates as a subsidiary of KBC Real Estate NV.
BEL 20 ended the session with DIEGEM KENNEDYCERT falling 7.74% to €105.14 on Wednesday, following the last session’s upward trend. BEL 20 dropped 0.57% to €3,879.87, following the last session’s downward trend on what was a somewhat bearish trend exchanging session today.
Volatility
DIEGEM KENNEDYCERT’s last week, last month’s, and last quarter’s current intraday variation average was 0.88%, 0.71%, and 2.87%.
DIEGEM KENNEDYCERT’s highest amplitude of average volatility was 0.88% (last week), 1.43% (last month), and 2.87% (last quarter).
Volume
Today’s last reported volume for DIEGEM KENNEDYCERT is 2 which is 81.81% below its average volume of 11.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, DIEGEM KENNEDYCERT’s stock is considered to be oversold (<=20).
More news about DIEGEM KENNEDYCERT.
8. TELEVERBIER (TVRB.PA)
-6.51% Price Change
Téléverbier SA engages in the operation of ski lifts in Switzerland. The company is involved in the car parks and locker activities; rental of operating buildings and building surfaces; operation of ski schools; sale and rental of sporting goods; operation of eleven high-altitude restaurants; and sale of catering products, as well as offers catering and accommodation services. It also operates garage workshop and spare parts store for the maintenance of piste groomers; metal construction workshop; and provides maintenance services for ski lift installations. Téléverbier SA was incorporated in 1950 and is headquartered in Verbier, Switzerland.
CAC 40 ended the session with TELEVERBIER falling 6.51% to €40.20 on Wednesday, after three consecutive sessions in a row of losses. CAC 40 slid 0.46% to €7,234.25, after three successive sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.
Earnings Per Share
As for profitability, TELEVERBIER has a trailing twelve months EPS of €0.96.
PE Ratio
TELEVERBIER has a trailing twelve months price to earnings ratio of 41.66. Meaning, the purchaser of the share is investing €41.66 for every euro of annual earnings.
Volatility
TELEVERBIER’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.94%, a negative 0.03%, and a positive 4.06%.
TELEVERBIER’s highest amplitude of average volatility was 4.39% (last week), 3.22% (last month), and 4.06% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, TELEVERBIER’s stock is considered to be overbought (>=80).
Volume
Today’s last reported volume for TELEVERBIER is 1254 which is 2750% above its average volume of 44.
More news about TELEVERBIER.
9. INTEROIL EXPL PROD (IOX.OL)
-5.5% Price Change
Interoil Exploration and Production ASA, together with its subsidiaries, operates as an upstream oil exploration and production company. It engages in the acquisition, exploration, development, and operation of oil and natural gas properties. The company's portfolio includes two producing licenses and two exploration licenses in Colombia; and one exploration and seven production concessions in Argentina. Interoil Exploration and Production ASA was incorporated in 2005 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with INTEROIL EXPL PROD falling 5.5% to €1.03 on Wednesday while Oslo Børs Benchmark Index_GI rose 0.13% to €1,242.54.
Earnings Per Share
As for profitability, INTEROIL EXPL PROD has a trailing twelve months EPS of kr0.01.
PE Ratio
INTEROIL EXPL PROD has a trailing twelve months price to earnings ratio of 103. Meaning, the purchaser of the share is investing kr103 for every norwegian krone of annual earnings.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, INTEROIL EXPL PROD’s stock is considered to be oversold (<=20).
More news about INTEROIL EXPL PROD.
10. ASM INTERNATIONAL (ASM.AS)
-4.92% Price Change
ASM International NV, together with its subsidiaries, engages in the research, development, manufacture, marketing, and servicing of equipment and materials that are used to produce semiconductor devices in the United States, Europe, and Asia. Its products include wafer processing deposition systems for single-wafer atomic layer deposition, plasma enhanced chemical vapor deposition, epitaxy, and batch diffusion/furnace systems, as well as provides spare parts and support services. The company also manufactures and sells equipment, which is used in wafer processing, encompassing the fabrication steps in which silicon wafers are layered with semiconductor devices. It serves manufacturers of semiconductor devices and integrated circuits. The company was formerly known as Advanced Semiconductor Materials International NV. ASM International NV was incorporated in 1968 and is headquartered in Almere, the Netherlands.
AEX-Index ended the session with ASM INTERNATIONAL dropping 4.92% to €307.10 on Wednesday, after two successive sessions in a row of gains. AEX-Index fell 0.47% to €749.38, following the last session’s downward trend on what was a somewhat negative trend trading session today.
Earnings Per Share
As for profitability, ASM INTERNATIONAL has a trailing twelve months EPS of €5.91.
PE Ratio
ASM INTERNATIONAL has a trailing twelve months price to earnings ratio of 51.96. Meaning, the purchaser of the share is investing €51.96 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.52%.
More news about ASM INTERNATIONAL.
Stay up to date with our winners and losers daily report
